“treatment resistant depression”的搜索结果，显示 51-60 项，共有 2646 项

1. 诊断与治疗 - 妙佑医疗国际

   This is known as refractory diffuse large B-cell lymphoma. CAR-T cell therapy. Chimeric antigen receptor (CAR)-T cell therapy trains the immune system cells to ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies. Rochester, Minn. The purpose of this study is to find out ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the safety and tolerability of ONO-7475 monotherapy in patients with relapsed or refractory acute myeloid leukemia or ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...

8. 诊断与治疗 - 妙佑医疗国际

   Follicular lymphoma treatments may include the "watch and wait" method, radiation therapy, immunotherapy, chemotherapy, targeted therapy, and CAR-T cell therapy ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...